Where: The Brookings Institution, Falk Auditorium, 1775 Massachusetts Ave, NW, Washington, DC
Although a great deal of attention concerning prescription drug prices centers on the prices charged
by pharmaceutical manufacturers themselves, markups in the distribution chain—pharmacy
benefit managers, wholesalers, and pharmacies—are often substantial. Despite the large role that
these actors play, little is known about the discounts they negotiate or markups they charge and
how those relate to what patientsultimately pay.
On Wednesday, June 14, the USC-Brookings Schaeffer Initiative for Innovation in Health Policy
will host a forum to explore the many segments of the drug distribution chain and examine proposals
to reduce price markups through increased competition.
The event will feature a presentation of two new papers: one estimating profitability in the distribution
chains of both branded and generic drugs and another proposing a transparency scheme to foster
competition in the distribution of generic pharmaceuticals. Stakeholder panels will follow the presentations
of these two papers, to discuss approaches to increase competition in brand and generic drug distribution.
After the session, panelists will take audience questions.